The prognosis for older patients with acute myeloid leukemia (AML) is poor: very few achieve remission and for those that don’t the option is largely palliative. Every year almost 1000 Australians die of the disease and clinical trials into new therapies for older patients have largely failed. A new Australian drug trial has achieved a […]